A detailed history of Avity Investment Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Avity Investment Management Inc. holds 117,240 shares of AMGN stock, worth $37.8 Million. This represents 2.99% of its overall portfolio holdings.

Number of Shares
117,240
Previous 118,542 1.1%
Holding current value
$37.8 Million
Previous $33.7 Million 8.69%
% of portfolio
2.99%
Previous 2.79%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$262.75 - $319.31 $342,100 - $415,741
-1,302 Reduced 1.1%
117,240 $36.6 Million
Q1 2024

Apr 16, 2024

SELL
$268.87 - $324.56 $612,485 - $739,347
-2,278 Reduced 1.89%
118,542 $33.7 Million
Q4 2023

Jan 11, 2024

BUY
$255.7 - $288.46 $1.33 Million - $1.5 Million
5,190 Added 4.49%
120,820 $34.8 Million
Q3 2023

Oct 18, 2023

SELL
$218.65 - $271.46 $1.74 Million - $2.16 Million
-7,942 Reduced 6.43%
115,630 $31.1 Million
Q2 2023

Jul 17, 2023

BUY
$214.27 - $253.37 $225,840 - $267,051
1,054 Added 0.86%
123,572 $27.4 Million
Q1 2023

Apr 18, 2023

BUY
$225.79 - $275.2 $1.21 Million - $1.47 Million
5,344 Added 4.56%
122,518 $29.6 Million
Q4 2022

Jan 12, 2023

BUY
$229.03 - $291.01 $701,289 - $891,072
3,062 Added 2.68%
117,174 $30.8 Million
Q3 2022

Oct 13, 2022

BUY
$224.46 - $253.15 $9.68 Million - $10.9 Million
43,130 Added 60.76%
114,112 $25.7 Million
Q2 2022

Jul 13, 2022

BUY
$230.71 - $256.74 $15.7 Million - $17.5 Million
68,257 Added 2504.84%
70,982 $17.3 Million
Q1 2022

Apr 19, 2022

SELL
$219.27 - $242.57 $5,481 - $6,064
-25 Reduced 0.91%
2,725 $659,000
Q2 2021

Jul 13, 2021

SELL
$233.58 - $259.14 $23,358 - $25,914
-100 Reduced 3.51%
2,750 $670,000
Q1 2021

Apr 15, 2021

SELL
$221.91 - $258.6 $66,573 - $77,580
-300 Reduced 9.52%
2,850 $709,000
Q3 2020

Oct 08, 2020

SELL
$234.65 - $260.95 $11,732 - $13,047
-50 Reduced 1.56%
3,150 $801,000
Q2 2020

Jul 15, 2020

SELL
$197.81 - $242.74 $9,890 - $12,137
-50 Reduced 1.54%
3,200 $755,000
Q1 2020

Apr 09, 2020

SELL
$182.24 - $241.7 $45,560 - $60,425
-250 Reduced 7.14%
3,250 $659,000
Q4 2019

Jan 15, 2020

BUY
$189.21 - $243.2 $18,921 - $24,320
100 Added 2.94%
3,500 $844,000
Q3 2019

Oct 10, 2019

BUY
$174.11 - $208.62 $65,291 - $78,232
375 Added 12.4%
3,400 $658,000
Q2 2019

Jul 22, 2019

BUY
$166.7 - $195.41 $504,267 - $591,115
3,025 New
3,025 $557,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Avity Investment Management Inc. Portfolio

Follow Avity Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avity Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avity Investment Management Inc. with notifications on news.